Erlotinib at a dose of 25 mg daily for non-small cell lung cancers with EGFR mutations

• Main Authors: Yeo, W.-L., Lau, M.W., Warner, J.L., Bodio, K., Huberman, M.S., Tenen, D.G., Kobayashi, S., Costa, D.B., Riely, G.J., Kris, M.G., Yeap, B.Y., Pao, W.
• Other Authors: MEDICINE
• Format: Article
• Published: 2011
• Subjects: EGFR; Epidermal growth factor receptor; Erlotinib; Exon 19 deletions; Gefitinib; L858R; Lung cancer; Mutation; Non-small cell lung cancer; Tyrosine kinase inhibitors
• Online Access: http://scholarbank.nus.edu.sg/handle/10635/27135
• Institution: National University of Singapore

10.1097/JTO.0b013e3181dd1386